ABSTRACT
Background Fluid overload, while common in the ICU and associated with serious sequelae, is hard to predict and may be influenced by ICU medication use. Machine learning (ML) approaches may offer advantages over traditional regression techniques to predict it. We compared the ability of traditional regression techniques and different ML-based modeling approaches to identify clinically meaningful fluid overload predictors.
Methods This was a retrospective, observational cohort study of adult patients admitted to an ICU ≥ 72 hours between 10/1/2015 and 10/31/2020 with available fluid balance data. Models to predict fluid overload (a positive fluid balance ≥10% of the admission body weight) in the 48-72 hours after ICU admission were created. Potential patient and medication fluid overload predictor variables (n=28) were collected at either baseline or 24 hours after ICU admission. The optimal traditional logistic regression model was created using backward selection. Supervised, classification-based ML models were trained and optimized, including a meta-modeling approach. Area under the receiver operating characteristic (AUROC), positive predictive value (PPV), and negative predictive value (NPV) were compared between the traditional and ML fluid prediction models.
Results A total of 49 of the 391 (12.5%) patients developed fluid overload. Among the ML models, the XGBoost model had the highest performance (AUROC 0.78, PPV 0.27, NPV 0.94) for fluid overload prediction. The XGBoost model performed similarly to the final traditional logistic regression model (AUROC 0.70; PPV 0.20, NPV 0.94). Feature importance analysis revealed severity of illness scores and medication-related data were the most important predictors of fluid overload.
Conclusion In the context of our study, ML and traditional models appear to perform similarly to predict fluid overload in the ICU. Baseline severity of illness and ICU medication regimen complexity are important predictors of fluid overload.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AHRQ
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The protocol for this study was approved with waivers of informed consent and HIPAA authorization granted by UNHCS Institutional Review Board (approval number: (Project00001541); approval date: October 2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
1120 15th Street, HM-118 Augusta, GA 30912, (706)-721-3826, sikora{at}uga.edu
Conflicts of Interest: The authors have no conflicts of interest.
Funding: Funding through Agency of Healthcare Research and Quality for Drs. Devlin, Murphy, Sikora, Smith, and Kamaleswaran was provided through R21HS028485 and R01HS029009.
Tianyi.zhang{at}uga.edu
david.j.murphy{at}emory.edu
Susan.smith{at}uga.edu
Brian.murray{at}unchealth.unc.edu
rkamaleswaran{at}emory.edu
xychen{at}uga.edu
mitchellsbuckley{at}gmail.com
rowes{at}ohsu.edu
j.devlin{at}northeastern.edu
Data Availability
All data produced in the present study are available upon reasonable request to the authors